Raising capital is one of the most competitive phases of the founder journey. But landing investor meetings isn't about pitching every venture capitalist (VC) in sight or sending cold emails with a generic deck, it's about passing the initial filter.
Before an investor ever agrees to a 30-minute call, they evaluate your startup against a specific set of underlying criteria. Knowing how to answer these core questions upfront is the difference between getting ignored and getting scheduled.
Here are the 7 key questions investors ask behind closed doors to determine if your startup is truly fundable and how to provide the right answers:
1. Is the problem statement clear, quantified and for a specific stakeholder in the value chain?
A quantified problem is easier to believe, prioritize and fund. A strong problem statement names the stakeholder, frequency and quantified economic impact.
2. Can this give me a 50x-100x return?
Venture funds operate on power-law economics: most startup investments fail or return minimal capital so a tiny fraction of portfolio companies must generate almost all fund returns. Investors are not just looking for a large Total Addressable Market (TAM) slide; they work backward from the exit.
To pass this test, your startup needs a clear, compounding narrative that bridges an urgent wedge to multi-billion-dollar expansion, attractive economics and scale defensibility.
3. Why is this the team to win?
The strongest team slide proves capability, it doesn’t just list biographies. Strong credentials are not enough if the team cannot execute in the next 18-24 months.
Investors back the combination of…
-
Founder market fit: Show the relevant industry experience, lived insight and customer understanding.
-
Technical + commercial capability: Explain how the team can both build and sell the product.
-
Execution history: Share speed, resilience, prior outcomes and the evidence of delivering milestones.
-
Critical gaps acknowledged: Mention key hires, advisors, regulatory, GTM or operational capabilities still required beyond your team.
Having a team that complements each other proves to investors that there is distinct capabilities, clear ownership and aligned full-time execution among the team.
Don’t have a team? Starting solo is okay, as long as you have a deliberate team-building plan, including the critical hires and potential co-founders you need to add.
4. What has actually been proven?
Traction isn't just revenue, it is evidence that de-risks the primary failure points of your business model. The KPI that matters most is the one that proves the next risk is coming down.
-
B2B SaaS: Proving retention, expansion and repeatable sales channels.
-
AI-Native: Proving active usage/retention, clear wedge and sustainable inference/compute economics.
-
Medical Devices / Life Sciences: Proving clinical safety, regulatory clearance and reimbursement pathways.
-
Deep Tech & Robotics: Proving technical feasibility, prototype milestones and unit economics.
5. Can this become a scalable, economically attractive business?
A strong product is not enough. The economics must work for both the customer and the company. Scalability requires a combination of strong demand, high customer ROI, repeat usage and healthy margins.
6. Does the round make financial sense?
Funding ask, valuation and dilution are all connected. It’s essential to design your round backwards from the next financeable milestone, not forward from a wish list.
Be prepared to specify:
-
Next Milestone: What exact evidence or metric will make the business financeable for the next round (e.g., growing from $800K ARR to $3M+ ARR)?
-
Runway & Burn: How many months are required and what is the monthly burn rate needed to execute?
-
Funding Ask & Dilution: Calculate the capital needed and check against current market valuation benchmarks to ensure realistic founder dilution.
7. What will this capital unlock and does it keep the company on a financeable path to a 50x-100x outcome?
Capital should buy the next proof point. Your financial roadmap must demonstrate how every dollar converts into stronger evidence and how that evidence moves you into a higher valuation tier.
Whether you are on a 7-year path to $50M–$100M+ ARR in SaaS or navigating clinical, regulatory and commercialization milestones in MedTech, investors need to see that this specific round positions you for long-term category leadership and massive exit potential.
Passing these 7 questions is the first step toward a successful fundraise. Looking to get ready for investors? Check out Communitech’s Investment Readiness Intensive Track program with Gaurav Bansal, a deep dive into how to build a fundable startup, before you pitch to investors.